The healthcare industry faces major challenges in creating new drugs that can improve outcomes in the treatment of all kinds of diseases. New generative AI models could play a major role in breaking through existing barriers, from lab research to successful clinical trials. Eventually, even AI-powered robots could help in the cause.

Nvidia VP of healthcare Kimberly Powell, one of Fast Company’s AI 20 honorees, has led the company’s health efforts for 17 years, giving her a big head start on understanding how to turn AI’s potential to improve our well-being into reality. Since it’s likely that everything from drug-discovery models to robotic healthcare aides would be powered by Nvidia chips and software, she’s in the right place to have an impact.

This Q&A is part of Fast Company’s AI 20

See Full Page